BACKGROUND: Human metapneumovirus (HMPV) is a recently discovered paramyxovirus that is a major cause of respiratory infections worldwide. OBJECTIVES: We aim to describe the molecular evolution of the HMPV F (fusion) and G (attachment) surface glycoproteins because they are targets for vaccines, monoclonal antibodies and antivirals currently in development. STUDY SETTING: Nasopharyngeal aspirates were collected in children <3 years old with acute respiratory infection in Quebec City during 2001-2010. HMPV-positive samples (n = 163) underwent HMPV-F and -G gene sequencing. Furthermore, HMPV-F (n = 124) and -G (n = 217) sequences were obtained from GenBank and other studies. Evolutionary analyses (phylogenetic reconstruction, sequence identity, detection of recombination and adaptive evolution) were computed. RESULTS: Sequences clustered into 5 genetic lineages (A1, A2a, A2b, B1 and B2). Multiple lineages circulated each year in Quebec City. With the exception of B1, each of the 5 subgroups was the predominant lineage during ≥1 season. The A1 lineage was not detected since 2002-2003 in our local cohort. There was no evidence of inter- or intragenic recombination. HMPV-F was highly conserved, whereas HMPV-G exhibited greater diversity. HMPV-F demonstrated strong evidence of purifying selection, both overall and in an abundance of negatively selected amino acid sites. In contrast, sites under diversifying selection were detected in all HMPV-G lineages (range, 4-15), all of which were located in the ectodomain. CONCLUSIONS: Predominant circulating HMPV lineages vary by year. HMPV-F is highly constrained and undergoes significant purifying selection. Given its high genetic variability, we found a modest number of positively selected sites in HMPV-G.
BACKGROUND:Human metapneumovirus (HMPV) is a recently discovered paramyxovirus that is a major cause of respiratory infections worldwide. OBJECTIVES: We aim to describe the molecular evolution of the HMPV F (fusion) and G (attachment) surface glycoproteins because they are targets for vaccines, monoclonal antibodies and antivirals currently in development. STUDY SETTING: Nasopharyngeal aspirates were collected in children <3 years old with acute respiratory infection in Quebec City during 2001-2010. HMPV-positive samples (n = 163) underwent HMPV-F and -G gene sequencing. Furthermore, HMPV-F (n = 124) and -G (n = 217) sequences were obtained from GenBank and other studies. Evolutionary analyses (phylogenetic reconstruction, sequence identity, detection of recombination and adaptive evolution) were computed. RESULTS: Sequences clustered into 5 genetic lineages (A1, A2a, A2b, B1 and B2). Multiple lineages circulated each year in Quebec City. With the exception of B1, each of the 5 subgroups was the predominant lineage during ≥1 season. The A1 lineage was not detected since 2002-2003 in our local cohort. There was no evidence of inter- or intragenic recombination. HMPV-F was highly conserved, whereas HMPV-G exhibited greater diversity. HMPV-F demonstrated strong evidence of purifying selection, both overall and in an abundance of negatively selected amino acid sites. In contrast, sites under diversifying selection were detected in all HMPV-G lineages (range, 4-15), all of which were located in the ectodomain. CONCLUSIONS: Predominant circulating HMPV lineages vary by year. HMPV-F is highly constrained and undergoes significant purifying selection. Given its high genetic variability, we found a modest number of positively selected sites in HMPV-G.
Authors: Pascal Mutz; Nash D Rochman; Yuri I Wolf; Guilhem Faure; Feng Zhang; Eugene V Koonin Journal: Proc Natl Acad Sci U S A Date: 2022-05-31 Impact factor: 12.779
Authors: Nina Moe; Sidsel Krokstad; Inger Heimdal Stenseng; Andreas Christensen; Lars Høsøien Skanke; Kari Ravndal Risnes; Svein Arne Nordbø; Henrik Døllner Journal: PLoS One Date: 2017-01-17 Impact factor: 3.240
Authors: Jacob D Negrey; Rachna B Reddy; Erik J Scully; Sarah Phillips-Garcia; Leah A Owens; Kevin E Langergraber; John C Mitani; Melissa Emery Thompson; Richard W Wrangham; Martin N Muller; Emily Otali; Zarin Machanda; David Hyeroba; Kristine A Grindle; Tressa E Pappas; Ann C Palmenberg; James E Gern; Tony L Goldberg Journal: Emerg Microbes Infect Date: 2019 Impact factor: 19.568
Authors: Betty E Owor; Geoffrey N Masankwa; Lilian C Mwango; Regina W Njeru; Charles N Agoti; D James Nokes Journal: BMC Infect Dis Date: 2016-06-17 Impact factor: 3.090